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INTRODUCTION
The purpose of this grant is to build instrumentation and imaging agents for photoacoustic imaging of breast cancer, using which one could estimate the change in molecular expression of various breast-cancer-specific proteins undergoing chemotherapy treatment. We've made significant progress towards obtaining this goal: 1) we have adapted our instrumentation hardware and image reconstruction software for allowing to acquire photoacoustic images of multiple contrast agents simultaneously; 2) We developed 5 new contrast agents based on carbon nanotubes and showed they exhibit 300-times higher sensitivity and for the first allow imaging photoacoustic molecular probes at sub-nanomolar concentrations (one paper published in Nano Letters and another was submitted to Nano Letters as well).
BODY

Major training milestones
Over the course of the last 2 years I have achieved most of the training milestones I have set for myself at the beginning of the training grant as well as others. As the previous yearly report did and clinical understanding of cancer and reaffirmed my desire to pursue a career as an independent investigator focusing on developing molecular imaging techniques for cancer patients, particularly breast cancer.
Developing new instrumentation hardware and image reconstruction software for
allowing multiplexing studies of more than one photoacoustic imaging agents.
Last year we reported on two new photoacoustic imaging agents we developed based on single walled carbon nanotubes (SWNTs) conjugated to optical dyes (Indocyanine green and QSY 21 ).
However, in order to allow each of these imaging agents to report on a different molecular activity in a tumor, instrumentation that allows multiplexing has to be in place. We have adapted our photoacoustic imaging instrument to allow multiple-wavelength acquisition between the wavelengths of 690 to 900 nm. We have then adapted the image reconstruction algorithm to calculate the photoacoustic spectrum of each voxel in the three-dimensional (3D) photoacoustic image and using least squares, calculate the relative amount of each of the imaging agents in this voxel. The algorithm then produces new 3D photoacoustic images representing the distribution of the imaging agent in the image (i.e., spectral unmixing the image to its spectral components). We tested this algorithm both in phantoms ( Fig. 1) as well as in living animals ( Fig. 2) and received very encouraging results, which we have submitted as a research paper to Nano Letters (see submitted manuscript in the appendix). Importantly, this is the very first time where true multiplexing capabilities are demonstrated with photoacoustic imaging. 
Development of 3 additional photoacoustic molecular imaging agents.
In addition to the SWNT-ICG and SWNT-QSY imaging agents, we have further exploited the pipi interactions of optical dyes with the hydrophobic surface of the single walled carbon nanotubes (SWNTs), and synthesized 3 additional photoacoustic molecular imaging agents.
The dyes we attached were Cy5.5, Methylene Blue, and Melanin, all of which produced a distinct optical absorbance spectra for a photoacoustic instrument to detect (Fig 3, see submitted manuscript in the appendix). 
Demonstrating of tumor targeting of SWNT-ICG and SWNT-QST photoacoustic imaging agents.
For the two newly developed photoacoustic imaging agents (SWNT-ICG and SWNT-QSY), we have attached an RGD peptide to their surface and demonstrated that despite their higher weight, they still preserved the excellent tumor targeting capabilities as plain SWNTs, while demonstrating great in-vivo sensitivity of over 300-times better than plain SWNTs (Fig. 4 , see paper in appendix that was published in 2010 in Nano Letters). . The ultrasound images show the skin and the tumor boundaries. Subtraction photoacoustic images were calculated as 2 hr post-injection minus pre-injection images. As can be seen in the subtraction images, SWNT-QSY-RGD as well as SWNT-ICG-RGD accumulate in significantly higher amounts in the tumor as compared to their respective control particles. (B) Quantitative region-of-interest analysis shows that SWNT-QSY-RGD creates a 3-fold higher photoacoustic signal increase in the tumor than the control SWNT-QSY-RAD particle (p < 0.01). SWNT-ICG-RGD provides over 100% higher photoacoustic signal increase than the control SWNT-ICG-RAD (p < 0.01). The error bars represent standard error (n = 3 mice).
KEY RESEARCH ACCOMPLISHMENTS
 Developed instrumentation hardware and image reconstruction software to allow imaging of multiple photoacoustic imaging agents simultaneously in living mice.
 Finished the development of a total of 6 photoacoustic imaging agents.
 Demonstrated the photoacoustic imaging agents can target tumors in living mice upon intravenous injection at sub-nanomolar sensitivities. 
REPORTABLE OUTCOMES

CONCLUSION
The main achievement over this past year was the development of 3 additional new photoacoustic imaging agents which allow reaching unprecedented sensitivities, adaptation of the photoacoustic instrument to allow true multiplexing studies in vitro as well as in animals, and finally, the demonstration of the tumor targeting of the new SWNT-based imaging agents.
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Abstract
Photoacoustic imaging is an emerging modality that overcomes to a great extent the resolution and depth limitations of optical imaging while maintaining relatively high-contrast. However, since many diseases will not manifest an endogenous photoacoustic contrast, it is essential to develop exogenous photoacoustic contrast agents that can target diseased tissue(s). Here we present a family of novel photoacoustic contrast agents that are based on the binding of small optical dyes to single walled carbon nanotubes (SWNT-dye). We synthesized five different SWNT-dye contrast agents using different optical dyes, creating five "flavors" of SWNT-dye nanoparticles. In particular, SWNT that were coated with either QSY 21 (SWNT-QSY) or
Indocyanine Green (SWNT-ICG) exhibited over 100-times higher photoacoustic contrast in living animals compared to plain SWNTs, leading to subnanomolar sensitivities. We then conjugated the SWNT-QSY and SWNT-ICG particles with cyclic Arg-Gly-Asp (RGD) peptides to molecularly target the α v β 3 integrin, which is associated with tumor angiogenesis. Intravenous administration of these tumor-targeted imaging agents to tumor-bearing mice showed significantly higher photoacoustic signal in the tumor than in mice injected with the untargeted contrast agent. Finally, we were able to spectrally separate the photoacoustic signals of SWNT-QSY and SWNT-ICG in living animals injected subcutaneously with both particles in the same location, opening the possibility for multiplexing in-vivo studies.
Introduction
Photoacoustic molecular imaging is an emerging imaging modality where disease-targeted imaging agents produce ultrasound waves in response to the absorption of short-pulsed laser light [1] [2] [3] [4] . The main advantage of the photoacoustic imaging modality is in its higher depth of penetration and spatial resolution, as compared with purely optical techniques. However, the main challenge in designing photoacoustic imaging agents is creating an agent that produces sufficient photoacoustic signal in order to be detected in low concentration, while being able to target the diseased tissue(s). Moreover, it is desirable to ha ve multiple imaging agents, each with a different optical spectrum so to allow multiplexing studies. In this work, we report on a general method to prepare a dye-enhanced single walled carbon nanotubes (SWNTs) photoacoustic imaging agents by coating small molecule dyes onto the surface of SWNTs. We show that the resulting imaging agents can target cancer-specific receptors in tumor-bearing mice, exhibit unprecedented high sensitivity and can be imaged simultaneously (multiplexed).
Results
We have recently reported on the conjugation of cyclic Arg-Gly-Asp (RGD) peptides to pegylated SWNTs 5 (SWNT-RGD) and their use as photoacoustic imaging agents 1 to image α v β 3 integrins, which are over-expressed in tumor vasculature. We then also reported on the binding of Indocyanine Green (ICG) to the surface of the SWNTs through pi-pi stacking 6 . This loading of ICG onto the surface of the SWNTs has resulted in significantly better in-vivo sensitivity than plain SWNTs. In this work we generalize this method and show it works for a number of optical dyes and quenchers including QSY 21 , Methylene Blue (MB), Cyanine dyes such as Cy5.5, and Melanin (Fig. 1a) . Control untargeted SWNT-dye particles were conjugated to a mutated nontargeted peptide, RAD that does not bind to α v β 3 integrins (see Supporting Information for more details on syntheses).
The ultra-high surface area to volume ratio of the nanotubes allowed for efficient loading of the optical dyes onto the nanotubes. The SWNT-dye conjugates exhibited a significant increase in the optical absorption compared to plain SWNTs to the extent of 120%, 88% and 30% increase for Methylene Blue, Cy5.5 and Melanin respectively (Fig. 1b) . Of most interest were ICG and QSY 21 dyes whose conjugates with SWNTs led to 20 and 17-fold increase in the particles" optical absorption respectively (Fig. 1c) . Furthermore, the spectra of SWNT-ICG and SWNT-QSY peak at different wavelengths; 710 nm and 780 nm respectively. We therefore selected SWNT-ICG and SWNT-QSY as the candidate molecular imaging agents to demonstrate multiplexing in this work. Importantly, the nanoparticles conjugated with RAD and RGD had nearly identical absorption spectra (see Supporting Information and Supple mentary Fig. S1 ),
suggesting that the peptide conjugation did not interfere with the particle"s photoacoustic signal.
We constructed a non-absorbing and non-scattering agarose phantom with inclusions of SWNT-QSY-RGD and SWNT-ICG-RGD and at increasing concentrations from 0.5 nM to 121.5 nM in multiples of 3 (n = 3 inclusions per concentration). We used our home-made photoacoustic imaging system (see Supplementary Information and Supple mentary Fig. S5) and scanned the phantom at 710 nm and 780 nm for the QSY-and ICG-coated particles respectively. The photoacoustic signal produced by the SWNT-QSY-RGD and SWNT-ICG-RGD particles correlated highly with the nanoparticle concentration (R 2 = 0.99 and 0.98 respectively) (Fig. 1c) .
We further validated that the new particles are stable in serum (see Supple mentary
Information and Supplementary Fig. S2 ). The particle"s photobleaching (i.e., loss of optical absorption due to continuous light exposure of the dye component of the nanoparticle) was characterized and found to be relatively small for SWNT-ICG, only 30% reduction in optical absorption after 60 min of laser irradiation at normal power density of 8 mJ/cm 2 . SWNT-QSY, however, showed higher light-sensitivity, resulting in a 50% reduction in optical absorption after 7 min of laser irradiation (see Supplementary Information and Supple mentary Fig. S3 ).
Finally, cell uptake studies showed specific binding of SWNT-QSY-RGD and SWNT-ICG-RGD to U87MG cells compared with the control particles SWNT-QSY-RAD and SWNT-ICG-RAD
respectively (see Supple mentary Information and Supplementary Fig. S4 ).
We then tested the particle"s sensitivity in living subjects by subcutaneously injecting the (Fig. 2a) . While the ultrasound image visualized the mouse anatomy (e.g., skin and inclusion edges), the photoacoustic image revealed the nanoparticles" contrast in the mouse tissue. The photoacoustic signal from each inclusion was quantified using a three dimensional region of interest (ROI) drawn over the inclusion volume. We observed a linear correlation (R 2 = 0.97 for both particles) between the nanoparticles concentration and the corresponding photoacoustic signal (Fig. 2b) . Tissue background signal was calculated as the average photoacoustic signal in areas where no nanoparticles were injected. Extrapolation of the signal-concentration graph reveals that 450 pM of SWNT-QSY-RGD and 170 pM of SWNT-ICG-RGD give the equivalent photoacoustic signal as the tissue background (i.e., signal to background ratio = 1). This value represents over 100-times improvement in sensitivity compared to plain SWNTs.
We then tested the nanoparticles targeting ability in living mice. Mice bearing U87MG
tumor xenografts (150 mm 3 in size) were injected through the tail vein (IV) with 200 μl of either SWNT-QSY-RGD (targeted) or SWNT-QSY-RAD (untargeted control) or the ICG-particles (n = 3 mice per group) at a concentration of 1.2 μM. We acquired 3D photoacoustic and ultrasound images of the entire tumor area before and 2 hours after the injection. Mice injected with the RGD-targeted nanoparticles showed significantly higher photoacoustic signal in the tumor compared with the control group injected with the RAD control particles (Fig. 3a) . The ultrasound images were used for visualizing the boundaries of the tumor as well as to validate that no significant movement (beyond 100 µm) had occurred throughout the experiment. While the tumor's photoacoustic signal before the injection is primarily due to the tumor's blood content, the photoacoustic signal post-injection is due to both the blood and the nanoparticles. To subtract out the background blood signal, subtraction images were calculated as the postinjection minus the pre-injection images, leaving the image only with the contrast made by the nanoparticles (Fig. 3a) . Measurement of the photoacoustic signal from a 3D ROI around the tumor (Fig. 3b) showed that the photoacoustic signal in the tumor was significantly higher in mice injected with the RGD-targeted nanoparticles as compared with the control particles (p < 0.01 for both QSY and ICG nanoparticles). For example, at 2 hours post-injection, mice injected with SWNT-QSY-RGD showed over 3-times higher photoacoustic signal increase in the tumor than mice injected with the control SWNT-QSY-RAD.
While the optical absorption spectra of SWNT-QSY and SWNT-ICG overlap, they are not identical, opening the possibility to spectrally unmix their signals, even at situations where they are spatially co-localized. We prepared an optically clear agarose-based phantom where in each of 5 wells, SWNT-QSY and SWNT-ICG were mixed in various ratios (pure SWNT-ICG, 1:3, 1:1, 3:1 and pure SWNT-QSY). Photoacoustic images at 700, 730, 760, 780, 800 nm were taken ( Fig. 4a) and used in a least squares method (see Supplementary Information for more details) to unmix the photoacoustic signals produced by the SWNT-QSY and the SWNT-ICG particles (Fig. 4b) .
Finally, we injected 30 µl of an equal mixture of SWNT-QSY and SWNT-ICG at 50 nM subcutaneously to a living mouse flank (Fig. 5a) . Control injections of 30 µl of SWNT-QSY and SWNT-ICG alone were injected subcutaneously to the mouse flank as well. Photoacoustic images at 700, 730, 760, 780, 800 nm (Fig. 5e) were used to spectrally unmix the SWNT-QSY and the SWNT-ICG signals. Indeed, the SWNT-QSY injection site showed only SWNT-QSY signal (Fig. 5b) , the SWNT-ICG injection site showed primarily SWNT-ICG signal (Fig. 5c), while the site that was injected with the equal mixture of particles showed both SWNT-QSY and SWNT-ICG signal (Fig. 5d) . At the area of injection, a slight separation of photoacoustic signals of the two channels (SWNT-QSY and SWNT-ICG) was observed. These image reconstruction artifacts are likely caused by slight movements of the mouse between the acquisition of consecutive photoacoustic images at different wavelengths, as well as differences in light tissue distribution between the five wavelengths.
Discussion
We have synthesized, characterized and demonstrated the application of dye-enhanced SWNTs as ultra-high sensitivity photoacoustic imaging agents. Concentrations of 170 pM and 450 pM were estimated to be the in-vivo sensitivity limits for the two nanoparticles, representing over 100-times improvement over plain SWNTs 1 and nearly 3-fold higher sensitivity than can be achieved using fluorescence imaging of quantum dots in living mice 7 . This improvement is likely due to both the higher optical absorption of the particles as well as the fact that the new particle"s While small optical dyes have lower optical absorption, they are also significantly smaller than nanoparticles. For example, ICG absorption coefficient divided by its molecular weight is still 7-times greater than that of a plain SWNT, or 9000-times greater than a gold nanorod with peak absorption at 780 nm. This suggests that creating a carrier for small optical dyes, such as SWNT, may be highly beneficial, as indeed shown in this work.
Photoacoustic imaging has been primarily used to visualize endogenous absorbers (e.g., hemoglobin and melanin) in the body [8] [9] [10] [11] . However, in order to visualize molecular characteristics of a tumor, an exogenous contrast agent that is specific for a given molecular target is required. Most work on photoacoustic contrast agents has been focused on gold nanoparticles [12] [13] [14] [15] [16] as well as other kinds of nanoparticles [17] [18] [19] and small molecules 20 . However, the main challenge that has yet been solved is the delivery of such agents to the tumor in sufficient amounts to create detectable and specific signal. High and rapid uptake of the nanoparticles by the reticuloendothelial system (RES) is likely the cause preventing the particles from accumulating at the tumor site in sufficient amounts. The SWNTs used here are 1-2 nm in diameter and 50-300 nm in length. It is believed that this size is maintained even after the conjugation of the small optical dyes to the SWNT surface, as the dyes are conjugated directly to the surface of the nanotube, under the polyethylene-glycol (PEG), thereby allowing the particles to keep a favorable bio-distribution as reported previously 5 . Hence, the dye-enhanced SWNTs presented in this work offer both unprecedented photoacoustic sensitivity as well as good tumors targeting capabilities upon intravenous injection. We have also previously published pilot toxicology studies of the SWNTs with encouraging results in mouse models 21 as well as observed they are able to be excreted via the biliary pathway 22, 23 .
The dye-enhanced SWNT photoacoustic contrast agents reported here have the capability to bind to molecular targets in living animals while maintaining a very high photoacoustic signal and present multiplexing capabilities. No other imaging modality or imaging agent can achieve both sub-nM sensitivity at large depths of penetration and sub-millimeter spatial resolution as can be achieved with photoacoustic imaging of dye-enhanced SWNTs. To our knowledge, this is the first demonstration of multiplexing of photoacoustic molecular imaging agents that are capable to molecularly target tumors in living animals.
Supporting Information
Description of particles synthesis, photoacoustic imaging instrument, experimental procedures, statistical methods, and in-vitro characterization of the particles including serum-stability, photobleaching and cell-uptake study. While overlapping, the optical absorption spectra of SWNT-QSY and SWNT-ICG are different, which allowed us to spectrally separate their photoacoustic signals both in a phantom as well as in living mice (see Figure) .
This is the first demonstration of true multiplexing of photoacoustic imaging agents that were also shown to target tumors in living mice.
Abstract submitted to Era of Hope 2011:
Photoacoustic Molecular Imaging using Carbon Nanotubes for Ultra-high Sensitivity Imaging of Breast Cancer In-vivo Background and objectives: Photoacoustic imaging is an emerging technology that provides non-invasive imaging at high spatial resolution and depth of penetration. Here we demonstrate photoacoustic molecular imaging, by designing a family of photoacoustic agents that selectively bind to molecular targets in tumors in living mice. Furthermore, we show the ability to resolve the signals of two imaging agents, thereby allowing multiplexing studies.
Methods:
We synthesized imaging agents based on a single walled carbon nanotube (SWNT) conjugated with polyethylene-glycol-5000 connected to Arg-Gly-Asp (RGD) peptide to target the α v β 3 integrins in tumor vasculature. The SWNT surface was conjugated with optical dyes including QSY 21 and Indocyanine Green (ICG), rendering the SWNTs unique optical spectra. Finally, we built a high resolution near infra-red photoacoustic system for mice imaging.
Results:
We measured the minimal detectable concentration of the dye-enhanced SWNTs in living mice to be 170 pM at a spatial resolution of 200 µm and depths of 3-4 cm. This represents over two orders of magnitude improvement in both sensitivity and spatial resolution over conventional optical imaging techniques. The particles showed a strong photoacoustic signal that is linear to their concentration and independent of the RGD conjugation. Cell-uptake studies using U87 cells (that express α v β 3 on the cell membrane) showed 75% higher binding of RGDtargeted SWNT as compared with untargeted SWNTs. We then showed that when RGD-targeted SWNTs are administered to tumor-bearing mice (n = 4) via the tail vein, they selectively bind to the α v β 3 integrins, producing a threedimensional photoacoustic image of their distribution in the tumor (Fig. 1) . Control untargeted particles showed 8-times lower photoacoustic signal in the tumor post-injection (p < 0.001). These results were verified ex-vivo using a Raman microscope that is sensitive to the SWNTs Raman signal. (de la Zerda et al, Nature Nanotechnology, 3, 557, 2008) Finally, we showed that the dye-SWNT particles (QSY 21 -and ICG-SWNTs) allow multiplexing studies and can be targeted to tumors in living mice (de la Zerda et al, Nano Letters, 10, 6, 2010; de la Zerda et al, Nano Letters, in review).
Conclusion:
We presented the first demonstration of photoacoustic molecular imaging and synthesized a family of imaging agents that allow the imaging of multiple molecular activities in tumor-bearing mice. While current breast imaging is limited primarily to anatomical features, photoacoustic molecular imaging provides molecular information in high resolution that may allow an early assessment of tumor"s response to neoadjuvant therapy. RGD-targeted SWNTs administered intravenously to living mice produced significantly higher photoacoustic signal in tumor compared to mice injected with non-targeted SWNTs.
